ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 531 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $970,586 | +5.4% | 12,445 | -8.4% | 0.18% | -8.0% |
| Q1 2024 | $920,858 | +27.0% | 13,592 | +34.2% | 0.20% | -2.5% |
| Q2 2023 | $725,004 | +45.4% | 10,130 | +37.7% | 0.20% | +2.0% |
| Q4 2022 | $498,601 | +75.6% | 7,354 | +50.8% | 0.20% | +19.8% |
| Q4 2021 | $284,000 | +12.3% | 4,876 | -14.2% | 0.17% | -27.4% |
| Q3 2019 | $253,000 | -66.4% | 5,682 | -69.5% | 0.23% | -46.0% |
| Q1 2019 | $754,000 | +5.0% | 18,646 | -1.3% | 0.43% | +12.1% |
| Q4 2018 | $718,000 | +135.4% | 18,901 | +117.3% | 0.38% | +291.8% |
| Q2 2018 | $305,000 | -64.0% | 8,700 | -64.1% | 0.10% | -52.9% |
| Q1 2018 | $848,000 | -10.9% | 24,262 | -13.7% | 0.21% | -23.7% |
| Q3 2017 | $952,000 | +17.8% | 28,100 | +18.6% | 0.27% | -3.2% |
| Q2 2017 | $808,000 | +93.8% | 23,700 | +86.6% | 0.28% | +13.4% |
| Q3 2016 | $417,000 | – | 12,700 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |